Arcus Biosciences (RCUS) Profit After Tax: 2017-2025
Historic Profit After Tax for Arcus Biosciences (RCUS) over the last 7 years, with Sep 2025 value amounting to -$135.0 million.
- Arcus Biosciences' Profit After Tax fell 46.74% to -$135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$433.0 million, marking a year-over-year decrease of 60.37%. This contributed to the annual value of -$283.0 million for FY2024, which is 7.82% up from last year.
- Latest data reveals that Arcus Biosciences reported Profit After Tax of -$135.0 million as of Q3 2025, which was down 20.54% from -$112.0 million recorded in Q1 2025.
- Arcus Biosciences' Profit After Tax's 5-year high stood at $279.5 million during Q4 2021, with a 5-year trough of -$135.0 million in Q3 2025.
- Over the past 3 years, Arcus Biosciences' median Profit After Tax value was -$86.5 million (recorded in 2023), while the average stood at -$83.7 million.
- Data for Arcus Biosciences' Profit After Tax shows a peak YoY increase of 639.10% (in 2021) and a maximum YoY decrease of 4,379.64% (in 2021) over the last 5 years.
- Arcus Biosciences' Profit After Tax (Quarterly) stood at $279.5 million in 2021, then tumbled by 123.97% to -$67.0 million in 2022, then declined by 20.90% to -$81.0 million in 2023, then fell by 16.05% to -$94.0 million in 2024, then slumped by 46.74% to -$135.0 million in 2025.
- Its last three reported values are -$135.0 million in Q3 2025, -$112.0 million for Q1 2025, and -$94.0 million during Q4 2024.